KR100687884B1 - 1 2 A Method for Mass Production of Recombinant Trypsin by Employing Regulatory Genes sgtR1 and sgtR2 from Streptomyces griseus - Google Patents

1 2 A Method for Mass Production of Recombinant Trypsin by Employing Regulatory Genes sgtR1 and sgtR2 from Streptomyces griseus Download PDF

Info

Publication number
KR100687884B1
KR100687884B1 KR1020050135536A KR20050135536A KR100687884B1 KR 100687884 B1 KR100687884 B1 KR 100687884B1 KR 1020050135536 A KR1020050135536 A KR 1020050135536A KR 20050135536 A KR20050135536 A KR 20050135536A KR 100687884 B1 KR100687884 B1 KR 100687884B1
Authority
KR
South Korea
Prior art keywords
trypsin
pwhm3
recombinant
streptomyces griseus
gene
Prior art date
Application number
KR1020050135536A
Other languages
Korean (ko)
Inventor
홍순광
장용근
김미선
김종희
Original Assignee
한국과학기술원
다인바이오 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국과학기술원, 다인바이오 주식회사 filed Critical 한국과학기술원
Priority to KR1020050135536A priority Critical patent/KR100687884B1/en
Application granted granted Critical
Publication of KR100687884B1 publication Critical patent/KR100687884B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6427Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A method for mass production of recombinant trypsin by using regulatory genes sgtR1 and sgtR2 derived from Streptomyces griseus is provided to improve production yield of trypsin compared to the conventional methods by using a transformant. A trypsin recombinant expression vector for transforming prokaryotes contains sprT gene derived from Streptomyces griseus, and sgtR1 and sgtR2 genes derived from Streptomyces griseus, wherein the trypsin recombinant expression vector is pWHM3-TR1, pWHM3-TR2 or pWHM3-TR1R2. The method for mass production of recombinant trypsin comprises the steps of: constructing the trypsin recombinant expression vector; producing transformed Streptomyces griseus with the trypsin recombinant expression vector; and culturing the transformed Streptomyces griseus and harvesting trypsin from the cultured medium.

Description

스트렙토마이시스 그리세우스 유래의 조절유전자 sgtR1 및 sgtR2를 이용한 재조합 트립신의 대량 생산방법{A Method for Mass Production of Recombinant Trypsin by Employing Regulatory Genes, sgtR1 and sgtR2 from Streptomyces griseus}A Method for Mass Production of Recombinant Trypsin by Employing Regulatory Genes, sgtR1 and sgtR2 from Streptomyces griseus}

도 1은 재조합 벡터 pWHM3-T, pWHM3-TR1, pWHM3-TR2 및 pWHM3-TR1R2의 유전자 지도를 각각 나타낸다.1 shows the genetic maps of recombinant vectors pWHM3-T, pWHM3-TR1, pWHM3-TR2 and pWHM3-TR1R2, respectively.

도 2는 재조합 벡터인 pWHM3-T와 pWHM3-TR1R2의 형질전환체에서 발현된 mRNA의 양을 간접적으로 비교한 전기영동사진이다. Figure 2 is an electrophoresis photograph indirectly comparing the amount of mRNA expressed in the transformants of the recombinant vector pWHM3-T and pWHM3-TR1R2.

본 발명은 스트렙토마이시스 그리세우스(Streptomyces griseus) 유래의 조절유전자 sgtR1 및 sgtR2를 이용한 재조합 트립신의 대량 생산방법에 관한 것이다. 좀 더 구체적으로, 본 발명은 트립신 유전자와 스트렙토마이시스 그리세우스로부터 유래한 조절유전자인 sgtR1 및 sgtR2를 포함하는 트립신의 재조합 발현벡터, 전기 발현벡터로 형질전환된 형질전환체 및 전기 형질전환체를 이용하여 재조합 트립신을 대량으로 생산하는 방법에 관한 것이다.The present invention is Streptomyces griseus ) and a method for mass production of recombinant trypsin using the regulatory genes sgt R1 and sgt R2. More specifically, the present invention provides a recombinant expression vector of a trypsin comprising a trypsin gene and a regulatory gene derived from Streptomyces griesus , sgt R1 and sgt R2, a transformant transformed with an electric expression vector, and an electric trait. The present invention relates to a method for mass production of recombinant trypsin using a transformant.

효소는 이미 오래전부터 특정기질에 선택적으로 반응하는 특징으로 인해 음료수제조, 육가공, 유가공, 양조, 제빵, 유지 산업과 효소센서 등 다양한 산업현장에서 유용하게 이용되고 있다. 현재, 산업적으로 활용되는 효소 중에서도 단백질분해효소는 청국장, 새우젓, 제빵, 치즈 등의 식품산업, 소화제, 소염제 등의 의약품과 세제를 만드는 등 여러 분야에서 상업적으로 중요한 역할을 하고 있다. Enzymes have been used in various industrial fields, such as beverage production, meat processing, dairy processing, brewing, baking, fats and oils, and enzyme sensors for a long time. Currently, proteolytic enzymes among industrially used enzymes play a commercially important role in various fields such as making foodstuffs such as Cheonggukjang, shrimp sauce, bakery, cheese, and medicines and detergents such as digestive and anti-inflammatory agents.

특히, 단백질분해효소 중에서도 다양한 기질에 대하여 효소반응성을 나타내는 트립신은 산업적으로 유용하게 활용되고 있다. 그러나, 세포외부로 분비되어 단백질성 기질을 분해하는 특성으로 인하여, 트립신은 세포내에서는 매우 낮은 농도로 존재하고, 일단 세포외부로 분비되어 효소반응을 수행한 후에는 신속하게 분해되기 때문에, 트립신 유전자를 이용한 유전자 재조합 방법을 이용하여도, 다른 효소에 비하여 상대적으로 생산수율이 낮다는 단점이 있다. 이러한 단점을 극복하기 위하여, 생산된 트립신의 활성을 향상시키거나 또는 트립신의 활성을 장시간 동안 유지시키기 위한 연구가 활발히 진행되고 있다. In particular, trypsin, which exhibits enzymatic reactivity to various substrates among proteolytic enzymes, has been industrially useful. However, because of the property of secreting extracellularly to break down proteinaceous substrates, trypsin genes are present in very low concentrations intracellularly and are rapidly degraded once secreted out of the cell and subjected to enzymatic reactions. Even when using a genetic recombination method, there is a disadvantage that the production yield is relatively lower than other enzymes. In order to overcome this drawback, studies are being actively conducted to improve the activity of the produced trypsin or to maintain the activity of trypsin for a long time.

예를 들어, 미국특허 제 6177268호에는 효소반응용액에 3 내지 10mmol/L의 칼슘이온 및 망간이온을 첨가하여 트립신의 효소활성 저하를 방지하는 단계를 포함하는 트립신의 효소활성을 향상시키는 방법이 개시되어 있고, 미국특허 제 5945328호에는 트립신 유전자를 균사성 곰팡이에 도입하여, 형질전환된 균사성 곰팡이를 제조하고, 이를 배양하여 효소활성이 향상된 트립신을 제조하는 방법이 개시되어 있으며, 미국특허 제 5804410호에는 트립신과 유사한 효소활성을 나타내면서도 장시간동안 효소활성을 나타낼 수 있는 신규한 단백질분해효소가 개시되어 있고, 국제특허공개 WO 02/061064호에는 돼지의 췌장세포에 피키아 파스토리스 균주를 접종시키고, 배양하여 효소활성이 향상된 트립신을 생산하는 방법이 개시되어 있다.For example, US Pat. No. 6,177,268 discloses a method for improving the enzyme activity of trypsin comprising adding 3 to 10 mmol / L of calcium ions and manganese ions to an enzyme reaction solution to prevent deterioration of the enzyme activity of trypsin. US Pat. No. 5945328 discloses a method for introducing a tryptic gene into a mycelial fungus, producing a transformed mycelial fungus, and culturing the same to produce an improved trypsin, US Pat. No. 5,804,410. No. discloses a novel protease that exhibits enzymatic activity similar to trypsin and can exhibit enzymatic activity for a long time. International Patent Publication No. WO 02/061064 discloses inoculation of Pichia pastoris strains into pancreatic cells of pigs. And a method for producing trypsin with improved enzymatic activity by culturing.

그러나, 이러한 방법을 사용하여 트립신의 효소활성을 향상시키더라도, 트립신 자체의 양이 증가되는 것은 아니기 때문에, 트립신을 일정수준 이상의 양으로 요구하는 산업적인 활용면에서는 근본적인 해결방안이 되지 않고 있는 실정이다.However, even if the enzyme activity of trypsin is improved by using this method, the amount of trypsin itself does not increase, so it is not a fundamental solution in terms of industrial applications requiring trypsin above a certain level. .

따라서, 트립신을 대량으로 생산할 수 있는 방법을 개발하여야 할 필요성이 대두되었다.Therefore, there is a need to develop a method for mass production of trypsin.

이에, 본 발명자들은 트립신을 대량으로 생산할 수 있는 방법을 개발하고자 예의 연구노력한 결과, 트립신 유전자와 함께 스트렙토마이시스 그리세우스(Streptomyces griseus)로부터 유래한 조절유전자인 sgtR1 및 sgtR2를 포함하는 발현벡터로 형질전환된 형질전환체를 이용할 경우, 재조합 트립신의 발현량을 획기적으로 향상시킬 수 있음을 확인하고, 본 발명을 완성하게 되었다.Accordingly, the present inventors have made intensive studies to develop a method for producing trypsin in large quantities. As a result, the present inventors expressed expressions including sgt R1 and sgt R2, which are regulatory genes derived from Streptomyces griseus together with the trypsin gene. When using a transformant transformed with a vector, it was confirmed that the expression level of recombinant trypsin can be significantly improved, and the present invention was completed.

결국, 본 발명의 주된 목적은 트립신 유전자와 함께 스트렙토마이시스 그리 세우스(Streptomyces griseus)로부터 유래한 조절유전자인 sgtR1 및 sgtR2를 포함하는 트립신 재조합 발현벡터를 제공하는 것이다.After all, the main object of the present invention is to provide a trypsin recombinant expression vector comprising sgt R1 and sgt R2, which are regulatory genes derived from Streptomyces griseus with trypsin gene.

본 발명의 다른 목적은 전기 트립신 재조합 발현벡터로 형질전환된 형질전환체를 제공하는 것이다.Another object of the present invention is to provide a transformant transformed with the trypsin recombinant expression vector.

본 발명의 또 다른 목적은 전기 형질전환체를 배양하고, 이로부터 트립신을 수득하는 공정을 포함하는 재조합 트립신의 대량 생산방법을 제공하는 것이다.Still another object of the present invention is to provide a method for mass production of recombinant trypsin, which comprises the step of culturing the transformant and obtaining trypsin therefrom.

본 발명의 재조합 트립신을 대량으로 생산하는 방법은 트립신 유전자와, 스트렙토마이시스 그리세우스(Streptomyces griseus) 유래의 조절유전자 sgtR1, 조절유전자 sgtR2 또는 이들 모두를 포함하는 트립신 재조합 발현벡터로 형질전환된, 스트렙토마이시스 그리세우스를 배양하고, 배양액으로부터 트립신을 수득하는 공정을 포함한다. 이때, 전기 트립신 유전자, 조절유전자 sgtR1 , 조절유전자 sgtR2를 포함하는 재조합 발현벡터는 특별히 제한되지 않으며, 전기 재조합 발현벡터로 형질전환된 스트렙토마이시스 그리세우스 균주 역시 특별히 제한되지 않는다.The method for mass production of recombinant trypsin of the present invention comprises a trypsin gene and Streptomyces culturing Streptomyces glisus transformed with a trypsin recombinant expression vector comprising a regulatory gene sgtR1 , a regulatory gene sgtR2 or both derived from griseus ) and obtaining trypsin from the culture. In this case, the recombinant expression vector including the electric trypsin gene, the regulatory gene sgtR1 , and the regulatory gene sgtR2 is not particularly limited, and the Streptomyces glisus strain transformed with the electric recombinant expression vector is not particularly limited.

본 발명자들은 트립신의 발현량을 향상시키기 위하여 연구를 진행하던 중, 다양한 단백질 분해효소를 생산하는 것으로 알려진 스트렙토마이시스 그리세우스에 주목하게 되었다. 지금까지 알려진 바에 의하면, 스트렙토마이시스 그리세우스는 트립신 유전자(sprT)를 포함하고, 전기 유전자의 하류에 기능을 알 수 없는 유전자 가 존재한다는 사실과 함께, 이의 염기서열이 보고되었으므로(참조: Koo, B.-J. et al,, Journal of Microbiology and Biotechnology, 8(4):333-340, 1998; GenBank accession no. AY588948). 전기 기능이 알려지지 않은 유전자가 트립신의 발현을 조절할 수 있을 것이라고 예상하였다.The present inventors came to pay attention to Streptomyces griceus, which is known to produce various proteolytic enzymes while researching to improve the expression level of trypsin. So far as is known, Streptomyces griesus contains trypsin gene ( sprT ) and its base sequence has been reported with the fact that there is an unknown gene downstream of the electric gene ( Ko , B.-J. et al, Journal of Microbiology and Biotechnology, 8 (4): 333-340, 1998; GenBank accession no. AY588948). It was anticipated that genes with unknown electrical function could regulate the expression of trypsin.

이에, 본 발명자들은 상술한 가정을 확인하기 위하여, sprT와 조절유전자를 함께 발현벡터에 도입하여 방선균에 형질전환시킨 결과, 상기 조절 유전자에 의하여 트립신의 발현량이 20배 이상으로 증가하였음을 확인하였다.Thus, the present inventors, in order to confirm the above-described assumption, as a result of transforming the actinomycetes by introducing the sprT and the regulatory gene together into the expression vector, it was confirmed that the expression level of trypsin increased by 20 times or more by the regulatory gene.

본 발명의 재조합 트립신 생산방법은 종래의 방법에 비하여 트립신의 생산성을 월등히 향상시킬 수 있으므로, 트립신을 이용한 제품의 경제적인 생산에 널리 활용될 수 있을 것이다.Recombinant trypsin production method of the present invention can significantly improve the productivity of trypsin compared to the conventional method, it will be widely used for economic production of trypsin-based products.

이하, 실시예를 통하여 본 발명을 보다 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다. Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention in more detail, it will be apparent to those of ordinary skill in the art that the scope of the present invention is not limited by these examples in accordance with the gist of the present invention. .

실시예 1: 스트렙토마이시스 그리세우스로부터 트립신 유전자 및 조절유전자의 수득 Example 1 Obtaining Trypsin Gene and Regulatory Gene from Streptomyces gliseus

스트렙토마이시스 그리세우스로부터 트립신 유전자(sprT)(서열번호 1) 및 이의 하류에 존재하는 조절유전자인 sgtR1(서열번호 2) 및 sgtR2(서열번호 3)를 수득하였다.Streptomyces System to give the trypsin gene (sprT) (SEQ ID NO: 1) and the sgt R1 regulatory gene present downstream thereof (SEQ ID NO: 2) and sgt R2 (SEQ ID NO: 3) from the draw three-house.

먼저, 스트렙토마이시스 그리세우스 TK24(Streptomyces griseus TK24, KCTC-9080)의 염색체 DNA를 대량분리하기 위해서, 전기 균주를 100 ㎖ R2YE 액체배지(sucrose 103g/L, 0.25g/L, 10.12g/L, glucose 10g/L, casamino acid 0.1g/L, yeast extract 5g/L, (0.5%) 5 ml/L, (3.68%) 40 ml/L, L-proline(20%) 7.5 ml/L, TES(5.73%, pH 7.2) 50 ml/L, trace element 1ml/L: 0.04g/L, 0.2g/L, 0.01g/L, 0.01g/L, 0.01g/L, 0.01g/L)에서 36시간 배양하고, 배양된 세포에 라이소자임 2 ㎎/㎖과 알엔에이즈(RNase)를 포함하는 완충액Ⅰ(0.3 M sucrose, 25 mM TrisHCl pH 8.0, 25 mM EDTA pH 8.0) 10㎖를 가하여, 37℃에서 1시간동안 반응시킨 다음, 10%(w/v) SDS용액 1,200㎕를 가하고 60℃에서 30분동안 반응시켰다. 이어, 5M NaCl 용액 2㎖을 가하고 2시간동안 천천히 교반한 다음, 클로로포름 15㎖를 추가하고 2시간동안 교반하였다. 그런 다음, 반응물을 3,500rpm에서 20분간 원심분리하여 상층액을 수득하고, 100% 에탄올 30㎖을 가한 후, 하룻밤동안 교반시켰다. 끝으로, 침전된 염색체 DNA를 수득하고, 이를 건조시킨 다음, 10㎖의 알엔에이즈-TE 완충액에 용해시켜 목적하는 염색체 DNA를 수득하였다.First of all, Streptomyces TK24 ( Streptomyces) griseus In order to mass isolate chromosomal DNA of TK24 , KCTC-9080, 100 ml R2YE medium (sucrose 103g / L, 0.25g / L, 10.12g / L, glucose 10g / L, casamino acid 0.1g / L) , yeast extract 5 g / L, (0.5%) 5 ml / L, (3.68%) 40 ml / L, L-proline (20%) 7.5 ml / L, TES (5.73%, pH 7.2) 50 ml / L, trace element 1ml / L: 0.04g / L, 0.2g / L, 0.01g / L, 0.01g / L, 0.01g / L, 0.01g / L) for 36 hours, and lysozyme 2mg / 10 ml of Buffer I (0.3 M sucrose, 25 mM TrisHCl pH 8.0, 25 mM EDTA pH 8.0) containing ㎖ and RNase was added and reacted at 37 ° C. for 1 hour, followed by 10% (w / v). 1,200 μl of SDS solution was added and reacted at 60 ° C. for 30 minutes. Then, 2 ml of 5M NaCl solution was added and stirred slowly for 2 hours, and then 15 ml of chloroform was added and stirred for 2 hours. The reaction was then centrifuged at 3,500 rpm for 20 minutes to give a supernatant, 30 ml of 100% ethanol was added and stirred overnight. Finally, the precipitated chromosomal DNA was obtained, dried, and then dissolved in 10 ml of Al-A-TE buffer to obtain the desired chromosomal DNA.

전기 염색체 DNA를 EcoRI 및 BglII로 처리하여 수득한 2.2kb 단편과, BglII 와 NcoI으로 처리하여 수득한 0.46kb 단편을 ptrc△T(TaKaRa Shuzo Co., Japan)에 삽입한 후, 다시 BglII와 HindIII로 처리하여 얻은 단편을, 대장균-방선균 공용벡터인 pWHM3 벡터(TaKaRa Shuzo Co., Japan)의 EcoRI 및 HindIII 부위에 도입하여, 9.82kb의 pWHM3-T 재조합 벡터를 작제하였다(참조: 도 1).The 2.2 kb fragment obtained by treating the electrochromosomal DNA with Eco RI and Bgl II and the 0.46 kb fragment obtained by treating with Bgl II and Nco I were inserted into ptrc ΔT (TaKaRa Shuzo Co., Japan), and then again. A fragment obtained by treatment with Bgl II and Hind III was introduced into the Eco RI and Hind III sites of the pWHM3 vector (TaKaRa Shuzo Co., Japan), which is an E. coli-actinomycetes covalent vector, to construct a 9.82 kb pWHM3-T recombinant vector. (See FIG. 1).

한편, 전기 수득한 염색체 DNA를 주형으로 하고, 프라이머 sgtR1-F (5'-CCCGCACGCTCTGCAGGCACGTACCG-3', pstI)(서열번호 4), sgtR1-R (5‘-CGCCCTCGACCTGGAGGTCTGCAGAACCG-3', pstI)(서열번호 5)을 이용한 PCR을 수행하여, 727bp 크기의 sgtR1 유전자 단편을 수득하였다.On the other hand, the obtained chromosomal DNA was used as a template, and primers sgtR1- F (5'-CCCGCACGCTCTGCAGGCACGTACCG-3 ', pst I) (SEQ ID NO: 4), sgt R1-R (5'-CGCCCTCGACCTGGAGGTCTGCAGAACCG-3', pst I) by performing PCR using a (SEQ ID NO: 5), to give the sgt R1 gene fragment of 727bp size.

또한, 전기 수득한 염색체 DNA를 주형으로 하고, sgtR2-F (5'-GCCGGCCCGGAAGCTTCGGTCGAAGG-3', HindIII)(서열번호 6), sgtR2-R (5'-CGGCCCCCTCAAGCTTCGACCCCTGC -3', HindIII)(서열번호 7)을 이용한 PCR을 수행하여, 671bp 크기의 sgtR2 유전자 단편을 수득하였다.In addition, the electrical yield and the chromosome DNA as a template, sgt R2-F (5'- GCCGGCCCGGAAGCTTCGGTCGAAGG-3 ', Hind III) ( SEQ ID NO: 6), sgtR2-R (5' -CGGCCCCCTCAAGCTTCGACCCCTGC -3', Hind III) ( by performing PCR using SEQ ID NO: 7) yielded the sgt R2 gene fragment of 671bp size.

끝으로, 전기 수득한 염색체 DNA를 주형으로 하고, 프라이머 sgtR1-F 와 프라이머 sgtR2-R을 이용한 PCR을 수행하여 1,223bp 크기의 sgtR1sgtR2 영역을 동시에 포함하는 유전자 단편을 수득하였다.Finally, using the obtained chromosomal DNA as a template, PCR was performed using primers sgtR1 -F and primers sgtR2 -R to obtain gene fragments containing sgtR1 and sgtR2 regions of 1,223bp size at the same time.

실시예 2: 트립신 재조합 벡터 및 이를 포함하는 형질전환체의 작제 Example 2 Construction of Trypsin Recombinant Vector and Transformant Comprising the Same

전기 실시예 1에서 수득한 3개의 유전자 단편을 각각 PstI 및 HindIII로 자 른 후, 동일한 제한효소를 처리한 pWHM3-T에 클로닝해서 sprT 유전자 하류에 sgtR1, sgtR2, sgtR1R2를 각각 도입한 재조합 벡터(pWHM3-TR1, pWHM3-TR2, pWHM3-TR1R2)를 작제하였다(참조: 도 1). 도 1은 재조합 벡터 pWHM3-T, pWHM3-TR1, pWHM3-TR2 및 pWHM3-TR1R2의 유전자 지도를 각각 나타낸다.The three gene fragments obtained in Example 1 were cut into Pst I and Hind III, respectively, and then cloned into pWHM3-T treated with the same restriction enzyme to sgt R1, sgt R2, and sgt R1R2 downstream of the spr T gene. Recombinant vectors introduced (pWHM3-TR1, pWHM3-TR2, pWHM3-TR1R2) were constructed (see Fig. 1). 1 shows the genetic maps of recombinant vectors pWHM3-T, pWHM3-TR1, pWHM3-TR2 and pWHM3-TR1R2, respectively.

한편, 스트렙토마이시스 그리세우스를 R2YE 액체배지 100㎖에서 2-3일간 배양한 후, 2,800rpm에서 5분간 원심분리하여 배양된 세포를 수득하였다. 이어, 라이소자임 20㎎이 용해된 P 완충액(sucrose 30.9g/L, K2SO4 75mg/L, MgCl2ㆍ6H2O 0.606g/L, trace element 0.6ml/L, KH2PO4 (0.5%) 10㎖, CaCl2ㆍH2O (3.68%) 100㎖, TES(0.25 M, pH 7.2) 100㎖) 10㎖에 수득한 세포를 현탁하여 30℃에서 한 시간 반응시키고, 여과하여, 원형질체를 수득하였다. 이어, P 완충액으로 수회 세척하고, -70℃에 보관하였다. On the other hand, Streptomyces glisus was incubated for 2 days in 100ml R2YE liquid medium, and then centrifuged for 5 minutes at 2,800rpm to obtain the cultured cells. Next, P buffer (lyucose 30.9g / L, K 2 SO 4 75mg / L, MgCl 2 6H 2 O 0.606g / L, trace element 0.6ml / L, KH 2 PO 4 in which 20 mg of lysozyme dissolved) (0.5%) 10 mL, 100 mL of CaCl 2 H 2 O (3.68%), 100 mL of TES (0.25 M, pH 7.2) was suspended, the cells obtained were reacted at 30 ° C for 1 hour, and filtered. , Protoplasts were obtained. It was then washed several times with P buffer and stored at -70 ° C.

전기 -70℃에 보관된 원형질체를 용해시키고, PEG 용액(sucrose (10.3%) 250㎖/l, K2SO4 (2.5%) 10㎖/l, trace element 2㎖/l, 5M CaCl2 0.2ml, 1M Tris maleic acid 0.5ml(pH 8.0)) 200㎕ 및 전기 수득한 각각의 재조합 벡터를 넣어 5분간 방치한 후, 미리 준비된 R2YE 평판배지에 도말하고 30℃에서 배양하였다. 그런 다음, 15시간이 경과한 후에 항생제와 0.4% 한천을 포함하는 액체배지 3 ㎖를 다시 도포하고, 완전히 건조되면, 30℃에서 4일간 더 배양하여 재조합 콜로니를 수득하여, 각각의 형질전환체를 작제하였다.Protoplasts stored at −70 ° C. were dissolved, PEG solution (sucrose (10.3%) 250 mL / l, K 2 SO 4 (2.5%) 10ml / l, trace element 2ml / l, 5M CaCl 2 0.2 ml, 1 M Tris maleic acid 0.5 ml (pH 8.0)) and 200 µl of each of the recombinant vectors thus obtained were left to stand for 5 minutes, and then plated in a pre-prepared R2YE plate medium and incubated at 30 ° C. Then, after 15 hours, 3 ml of the liquid medium containing antibiotics and 0.4% agar was again applied, and when completely dried, incubated for 4 more days at 30 ° C. to obtain recombinant colonies, and each transformant was It was constructed.

실시예 3: 각 형질전환체가 생산한 트립신의 활성 측정 Example 3 Determination of Trypsin Activity Produced by Each Transformant

전기 실시예 2에서 제조된 재조합 벡터 pWHM3-T, pWHM3-TR1, pWHM3-TR2 및 pWHM3-TR1R2로 형질전환된 각 형질전환체를 상기 R2YE 액체배지에서 3일, 5일, 7일간 배양하고, 5,000rpm으로 3분간 원심분리하여 상층액을 수득하여, 이를 시료로서 사용하였다.Each transformant transformed with the recombinant vectors pWHM3-T, pWHM3-TR1, pWHM3-TR2 and pWHM3-TR1R2 prepared in Example 2 were cultured in the R2YE liquid medium for 3 days, 5 days, 7 days, and 5,000 Centrifugation at rpm for 3 minutes yielded a supernatant, which was used as a sample.

Tris 완충용액(pH 8.0) 890ul에 1mg/ml의 농도로 트립신 기질(N-α-benzoyl-DL-arginine-ρ-nitroanilide)이 용해된 DMSO용액 10ul를 혼합하고, 전기 준비된 각각의 상층액 시료 100ul를 혼합한 다음, 37℃에서 1시간 동안 반응시켰다. 이어, 30%(v/v) 아세트산을 가하여 반응을 종결시키고, 405 nm에서 흡광도를 측정하여, 측정값을 트립신의 활성으로 환산하고(참조: Koo, B.-J. et al,, Journal of Microbiology and Biotechnology, 8(4):333-340, 1998). 각 형질전환체별로 비교하였다. 이때, 대조군으로는 아무 것도 도입되지 않은 벡터 pWHM3를 사용하였다(참조: 표 1).10ul of DMSO solution in which trypsin substrate (N-α-benzoyl-DL-arginine-ρ-nitroanilide) was dissolved in 890ul of Tris buffer (pH 8.0) at a concentration of 1mg / ml, and 100ul of each supernatant sample prepared before Were mixed and reacted at 37 ° C. for 1 hour. Subsequently, 30% (v / v) acetic acid was added to terminate the reaction, absorbance was measured at 405 nm, and the measured value was converted to trypsin activity (see Koo, B.-J. et al, Journal of Microbiology and Biotechnology, 8 (4): 333-340, 1998). Comparison was made for each transformant. At this time, the vector pWHM3 into which nothing was introduced was used (see Table 1).

각 재조합 벡터로 형질전환된 형질전환체에서 발현된 트립신의 활성비교(OD405)Activity comparison of trypsin expressed in transformants transformed with each recombinant vector (OD 405 ) 재조합 벡터Recombinant vector 배양일Culture 3일3 days 5일5 days 7일7 days 대조군 pWHM3-T pWHM3-TR1 pWHM3-TR2 pWHM3-TR1R2Control pWHM3-T pWHM3-TR1 pWHM3-TR2 pWHM3-TR1R2 0.029 0.01 0.028 0.097 0.2040.029 0.01 0.028 0.097 0.204 0.039 0.015 0.048 0.186 0.3920.039 0.015 0.048 0.186 0.392 0.023 0.061 0.102 0.400 0.5420.023 0.061 0.102 0.400 0.542

상기 표 1에서 보듯이, 트립신 유전자를 포함하는 재조합 벡터를 포함하는 형질전환체에서 발현된 트립신은 배양기간이 경과함에 따라 활성이 향상되었고, 트립신 유전자만을 포함하는 재조합 벡터를 포함하는 형질전환체에서 발현된 트립신 보다는 트립신 유전자와 조절유전자를 포함하는 재조합 벡터를 포함하는 형질전환체에서 발현된 트립신의 활성이 향상되었다. 특히, 트립신 유전자와 두가지 조절유전자를 포함하는 재조합 벡터를 포함하는 형질전환체에서 발현된 트립신의 활성이 갖아 높은 수준을 나타내었다.As shown in Table 1, the trypsin expressed in the transformant containing a recombinant vector containing the trypsin gene activity was improved as the culture period elapsed, in the transformant containing a recombinant vector containing only the trypsin gene The activity of trypsin expressed in a transformant comprising a recombinant vector comprising a trypsin gene and a regulatory gene, rather than the expressed trypsin. In particular, the activity of trypsin expressed in a transformant comprising a recombinant vector comprising a trypsin gene and two regulatory genes showed high levels.

이러한 활성의 변화는 동일한 트립신 유전자를 포함한다는 점을 감안하면, 트립신의 발현량의 변화에 기인한 것으로 분석되었는 바, 조절유전자를 포함하는 재조합 벡터는 트립신의 발현량을 증가시킬 수 있음을 확인하였다.Considering that the change in activity includes the same trypsin gene, it was analyzed that the change in the expression level of trypsin was found, and it was confirmed that the recombinant vector containing the regulator gene could increase the expression level of trypsin. .

실시예 4: 역중합효소연쇄반응(RT-PCR)에 의한 트립신 유전자의 발현량 비교 Example 4 Comparison of Expression of Trypsin Gene by Reverse Polymerase Chain Reaction (RT-PCR)

조절유전자인 sgtR1 과 sgtR2에 의한 트립신의 발현량 증가가 어떤 단계에서 조절받는지를 확인하기 위하여, 트립신 유전자(sprT)의 발현량을 mRNA양으로 비교하였다: 즉, pWHM3-T와 pWHM3-TR1R2의 형질전환체를 R2YE 액체배지에서 2일 및 6일동안 배양하여 총 RNA를 추출하였다. 추출한 총 RNA에 DNase 처리를 하여 DNA를 제거한 후, 순수한 RNA를 수득하고, 이를 이용하여 역중합효소연쇄반응을 실시하여 각각의 cDNA를 수득하고, 전기영동하여 비교하였다(참조: 도 2). 도 2는 재조합 벡터인 pWHM3-T와 pWHM3-TR1R2의 형질전환체에서 발현된 mRNA의 양을 간접적으로 비교한 전기영동사진으로, M은 마커이고, 1번 레인은 2일동안 배양한 pWHM3-T의 형질전환체이며, 2번 레인은 2일동안 배양한 pWHM3-TR1R2의 형질전환체이고, 3번 레인은 6일동안 배양한 pWHM3-T의 형질전환체이며, 4번 레인은 6일동안 배양한 pWHM3-TR1R2의 형질전환체이다.To determine at what stage the increase in trypsin expression by the regulatory genes sgt R1 and sgt R2 is regulated, the expression levels of the trypsin gene ( sprT ) were compared by mRNA levels: pWHM3-T and pWHM3-TR1R2 Transformants were cultured in R2YE liquid medium for 2 and 6 days to extract total RNA. After removing DNA by DNase treatment on the extracted total RNA, pure RNA was obtained, and reverse polymerase chain reaction was used to obtain respective cDNAs and compared by electrophoresis (see FIG. 2). 2 is an electrophoresis photograph indirectly comparing the amount of mRNA expressed in the transformants of pWHM3-T and pWHM3-TR1R2 recombinant vectors, where M is a marker and lane 1 is pWHM3-T cultured for 2 days Lane 2 is a transformant of pWHM3-TR1R2 cultured for 2 days, lane 3 is a transformant of pWHM3-T cultured for 6 days, lane 4 is cultured for 6 days One pWHM3-TR1R2 is a transformant.

도 2에서 보듯이, sprT 유전자만이 도입된 pWHM3-T 형질전환체의 경우 sprT의 발현이 2일째에는 관찰되지 않고 6일째에만 관찰되었으나, 조절유전자 sgtR1sgtR2가 함께 도입된 pWHM3-TR1R2의 경우는 sprT의 발현이 2일째부터 상당량 유도되었고, 6일째에는 pWHM3-T 형질전환체의 경우보다 현저하게 과량으로 발현되는 것을 확인할 수 있었다. 이러한 결과는 조절 유전자의 공동 발현이 sprT 유전자의 발현을 세포성장의 초기에서부터 후기까지 안정되게 과량으로 유전자 전사를 유지시키고 있음을 암시하였다.As shown in Figure 2, sprT For pWHM3-TR1R2 a was observed only after 6 days without For pWHM3-T transformant genes only introduced the expression of the second day of the spr T is not observed, control gene sgtR1 and sgtR2 is introduced with the expression of the spr T Significant induction was induced from day 2, and on day 6 it was confirmed that it is significantly overexpressed than in the case of pWHM3-T transformants. These results suggest that co-expression of regulatory genes maintains gene transcription in excess of stable sprT gene expression from early to late cell growth.

이상에서 상세히 설명하고 입증하였듯이, 본 발명은 트립신 유전자와 스트렙 토마이시스 그리세우스(Streptomyces griseus)로부터 유래한 조절유전자인 sgtR1 및 sgtR2를 포함하는 트립신의 재조합 발현벡터, 전기 발현벡터로 형질전환된 형질전환체 및 전기 형질전환체를 이용하여 재조합 트립신을 대량으로 생산하는 방법을 제공한다. 본 발명의 재조합 트립신 생산방법은 종래의 방법에 비하여 트립신의 생산성을 월등히 향상시킬 수 있으므로, 트립신을 이용한 제품의 경제적인 생산에 널리 활용될 수 있을 것이다.As described and demonstrated in detail above, the present invention is transformed with a recombinant expression vector and an electric expression vector of trypsin, including sgt R1 and sgt R2, which are regulatory genes derived from trypsin gene and Streptomyces griseus The present invention provides a method for mass production of recombinant trypsin using the transformants and the electric transformants. Recombinant trypsin production method of the present invention can significantly improve the productivity of trypsin compared to the conventional method, it will be widely used for economic production of trypsin-based products.

서열목록 전자파일 첨부 Attach sequence list electronic file

Claims (4)

스트렙토마이시스 그리세우스(Streptomyces griseus) 유래의 트립신 유전자(sprT)와, 스트렙토마이시스 그리세우스(Streptomyces griseus) 유래의 조절유전자 sgtR1, 조절유전자 sgtR2 또는 이들 모두를 포함하고, 원핵생물을 형질전환시킬 수 있는 트립신 재조합 발현벡터.Streptomyces cis draw and aged mouse (Streptomyces griseus), including both the trypsin gene (sprT) derived, Streptomyces cis draw three-house (Streptomyces griseus) derived from the control gene sgtR1, regulatory genes sgtR2 thereof, transforming a prokaryotic Trypsin recombinant expression vector. 제 1항에 있어서,The method of claim 1, 도 1에 개시된 pWHM3-TR1, pWHM3-TR2 또는 pWHM3-TR1R2인 것을 특징으로 하는PWHM3-TR1, pWHM3-TR2 or pWHM3-TR1R2 disclosed in FIG. 트립신 재조합 발현벡터.Trypsin recombinant expression vector. 제 1항의 재조합 발현벡터로 형질전환된, 스트렙토마이시스 그리세우스(Streptomyces griseus). Streptomyces griseus , transformed with the recombinant expression vector of claim 1. 제 3항의 형질전환된 스트렙토마이시스 그리세우스(Streptomyces griseus)를 배양하고, 배양액으로부터 트립신을 수득하는 공정을 포함하는, 재조합 트립신을 대량으로 생산하는 방법. A method of mass producing recombinant trypsin comprising culturing the transformed Streptomyces griseus of claim 3 and obtaining trypsin from the culture.
KR1020050135536A 2005-12-30 2005-12-30 1 2 A Method for Mass Production of Recombinant Trypsin by Employing Regulatory Genes sgtR1 and sgtR2 from Streptomyces griseus KR100687884B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020050135536A KR100687884B1 (en) 2005-12-30 2005-12-30 1 2 A Method for Mass Production of Recombinant Trypsin by Employing Regulatory Genes sgtR1 and sgtR2 from Streptomyces griseus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020050135536A KR100687884B1 (en) 2005-12-30 2005-12-30 1 2 A Method for Mass Production of Recombinant Trypsin by Employing Regulatory Genes sgtR1 and sgtR2 from Streptomyces griseus

Publications (1)

Publication Number Publication Date
KR100687884B1 true KR100687884B1 (en) 2007-02-27

Family

ID=38104826

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020050135536A KR100687884B1 (en) 2005-12-30 2005-12-30 1 2 A Method for Mass Production of Recombinant Trypsin by Employing Regulatory Genes sgtR1 and sgtR2 from Streptomyces griseus

Country Status (1)

Country Link
KR (1) KR100687884B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101190078B1 (en) 2011-11-29 2012-10-11 명지대학교 산학협력단 Recombinant expression vector to produce beta-agarase, transformed microorganisms, and method for producing beta-agarase

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050069534A1 (en) 2001-12-10 2005-03-31 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050069534A1 (en) 2001-12-10 2005-03-31 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
논문

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101190078B1 (en) 2011-11-29 2012-10-11 명지대학교 산학협력단 Recombinant expression vector to produce beta-agarase, transformed microorganisms, and method for producing beta-agarase

Similar Documents

Publication Publication Date Title
EP2875120B1 (en) Amylase-deficient strain
DK2875119T3 (en) AGSE-DEFICIENT TRIALS
CN110520520A (en) For increasing the composition and method that protein generates in bacillus licheniformis
CA2345356A1 (en) Transformation system in the field of filamentous fungal hosts
CN104053780A (en) Ribosomal promotors from b. subtilis for protein production in microorganisms
CN113528476B (en) Glucose oxidase mutant and coding gene and efficient recombinant expression thereof
Madhavan et al. Expression system for heterologous protein expression in the filamentous fungus Aspergillus unguis
CN107250365A (en) Enhanced protein expression
US11655464B2 (en) Alkaline protease mutant, and gene, engineered strain, preparation method and application thereof
EP4090738A1 (en) Compositions and methods for enhanced protein production in bacillus licheniformis
EP2267007A1 (en) New gene products of bacillus licheniformis forming or decomposing polyamino acids and associated improved biotechnological production method
EP1012301A1 (en) TOTAL SYNTHESIS AND FUNCTIONAL OVEREXPRESSION OF A $i(CANDIDA RUGOSA) LIP1 GENE CODING FOR A MAJOR INDUSTRIAL LIPASE
KR100687884B1 (en) 1 2 A Method for Mass Production of Recombinant Trypsin by Employing Regulatory Genes sgtR1 and sgtR2 from Streptomyces griseus
CN103608457A (en) Expression method
DK2340306T3 (en) EXPRESSION-AMPLIFIED NUCLEIC ACIDS
CN109055417B (en) Recombinant microorganism, preparation method thereof and application thereof in production of coenzyme Q10
US20240101611A1 (en) Methods and compositions for producing proteins of interest in pigment deficient bacillus cells
WO2023023642A2 (en) Methods and compositions for enhanced protein production in bacillus cells
US20220282234A1 (en) Compositions and methods for increased protein production in bacillus lichenformis
EP4058553A1 (en) Compositions and methods for enhanced protein production in bacillus cells
JP5507062B2 (en) High expression promoter
EP1680502A2 (en) Recombinant microorganism
CN112105740A (en) Long-chain non-coding RNA expression in fungal hosts
WO2024004983A1 (en) Erythritol utilization-deficient mutant trichoderma spp. and method for producing target substance using same
JP2005052116A (en) High activity promoter and use thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130214

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20140210

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20150217

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20160202

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20170316

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20180205

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20190313

Year of fee payment: 13